Dobryszycka W, Katnik-Prastowska I, Gerber J, Lemańska K, Utko K, Rozdolski K
Department of Pharmaceutical Biochemistry, University Medical School, Wrocław, Poland.
Arch Immunol Ther Exp (Warsz). 1999;47(4):229-36.
In sera of women with malignant and non-malignant ovarian tumors, concentrations of the following proteins were determined: haptoglobin, measured by the reactions either with hemoglobin (Hp-Hb) or with concanavalin A (Hp-Con A), CA 125 antigen and interleukin 6 (IL-6). Besides preoperative data, obtained from all the patients and the group of healthy women, in the patients with ovarian cancer (III/IV FIGO stages) effects of administration of cytostatics were measured by monitoring changes in the levels of the examined parameters through the course of the therapy. All the results were submitted to statistical evaluation which showed differences and correlations among definite groups (normal/non-malignant, normal/cancers, non-malignant/cancers). Similar results were obtained for Hp-Hb and CA 125 determination. Moreover, a correlation between haptoglobin level and age was found. Patterns of monitoring revealed a surprising absence of Hp-Con A interaction in some cases.
在患有恶性和非恶性卵巢肿瘤的女性血清中,测定了以下蛋白质的浓度:通过与血红蛋白(Hp-Hb)或伴刀豆球蛋白A(Hp-Con A)反应测定的触珠蛋白、CA 125抗原和白细胞介素6(IL-6)。除了从所有患者和健康女性组获得的术前数据外,对于卵巢癌患者(国际妇产科联盟(FIGO)III/IV期),通过在治疗过程中监测所检测参数水平的变化来测定细胞抑制剂给药的效果。所有结果都进行了统计评估,结果显示特定组(正常/非恶性、正常/癌症、非恶性/癌症)之间存在差异和相关性。触珠蛋白与CA 测定得到了相似的结果。此外,还发现触珠蛋白水平与年龄之间存在相关性。监测模式显示在某些情况下令人惊讶地不存在Hp-Con A相互作用。